Multi-Site Feasibility Testing of the Ventricular Assist Device Anticipatory Guidance Tool

Launched by BRYAN HEART · Feb 7, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new tool designed to help patients understand what to expect before and after getting a Ventricular Assist Device (VAD), which is a device that helps the heart pump blood in people with advanced heart failure. The goal is to improve patient care by providing better education about life with a VAD, focusing on common feelings and concerns at different times after the surgery, such as 3, 6, 12, and 24 months later. The researchers have developed this tool based on feedback from patients and healthcare providers to ensure it addresses the most important aspects of living with a VAD.

To participate in this trial, you need to be at least 19 years old, speak English, and be scheduled to receive a VAD implant. If you join, you can expect to help evaluate this tool, which aims to improve understanding and satisfaction for future patients. It's an opportunity to share your experiences and contribute to better support for others in similar situations.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• (For patient inclusion):
• • scheduled for a VAD implantation
• • English-speaking as the VAD AG Tool v5.0 has not yet been translated beyond English age ≥19 years at the time of implant as most states in North America have an age of majority for consent signing.
• • (-VAD clinician for the clinician evaluation process)
• Exclusion Criteria:
• • Not scheduled for VAD surgery
• • Non English speaking
• • \<19 yrs of age (Not a VAD Clinician for the clinician evaluation process)